English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 98 | Tables: 217 | Pharma & Healthcare
To prevent sensitisation in cases where the mother’s immune system may attack the baby’s red blood cells during pregnancy, thus avoiding harm to the foetus.
The global market for Anti-D Immunoglobulin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-D Immunoglobulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-D Immunoglobulin by region & country, by Type, and by Application.
The Anti-D Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-D Immunoglobulin.
Market Segmentation
By Company
Octapharma
Kedrion Biopharma
Grifols
Saol Therapeutics
Bayer
Bio Products Laboratory
Segment by Type:
Vial
Prefilled Syringes
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-D Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-D Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-D Immunoglobulin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Anti-D Immunoglobulin Product Introduction
1.2 Global Anti-D Immunoglobulin Market Size Forecast
1.2.1 Global Anti-D Immunoglobulin Sales Value (2019-2030)
1.2.2 Global Anti-D Immunoglobulin Sales Volume (2019-2030)
1.2.3 Global Anti-D Immunoglobulin Sales Price (2019-2030)
1.3 Anti-D Immunoglobulin Market Trends & Drivers
1.3.1 Anti-D Immunoglobulin Industry Trends
1.3.2 Anti-D Immunoglobulin Market Drivers & Opportunity
1.3.3 Anti-D Immunoglobulin Market Challenges
1.3.4 Anti-D Immunoglobulin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-D Immunoglobulin Players Revenue Ranking (2023)
2.2 Global Anti-D Immunoglobulin Revenue by Company (2019-2024)
2.3 Global Anti-D Immunoglobulin Players Sales Volume Ranking (2023)
2.4 Global Anti-D Immunoglobulin Sales Volume by Company Players (2019-2024)
2.5 Global Anti-D Immunoglobulin Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-D Immunoglobulin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-D Immunoglobulin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-D Immunoglobulin
2.9 Anti-D Immunoglobulin Market Competitive Analysis
2.9.1 Anti-D Immunoglobulin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-D Immunoglobulin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-D Immunoglobulin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Vial
3.1.2 Prefilled Syringes
3.2 Global Anti-D Immunoglobulin Sales Value by Type
3.2.1 Global Anti-D Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-D Immunoglobulin Sales Value, by Type (2019-2030)
3.2.3 Global Anti-D Immunoglobulin Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-D Immunoglobulin Sales Volume by Type
3.3.1 Global Anti-D Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-D Immunoglobulin Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-D Immunoglobulin Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-D Immunoglobulin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Anti-D Immunoglobulin Sales Value by Application
4.2.1 Global Anti-D Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-D Immunoglobulin Sales Value, by Application (2019-2030)
4.2.3 Global Anti-D Immunoglobulin Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-D Immunoglobulin Sales Volume by Application
4.3.1 Global Anti-D Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-D Immunoglobulin Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-D Immunoglobulin Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-D Immunoglobulin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-D Immunoglobulin Sales Value by Region
5.1.1 Global Anti-D Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-D Immunoglobulin Sales Value by Region (2019-2024)
5.1.3 Global Anti-D Immunoglobulin Sales Value by Region (2025-2030)
5.1.4 Global Anti-D Immunoglobulin Sales Value by Region (%), (2019-2030)
5.2 Global Anti-D Immunoglobulin Sales Volume by Region
5.2.1 Global Anti-D Immunoglobulin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-D Immunoglobulin Sales Volume by Region (2019-2024)
5.2.3 Global Anti-D Immunoglobulin Sales Volume by Region (2025-2030)
5.2.4 Global Anti-D Immunoglobulin Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-D Immunoglobulin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-D Immunoglobulin Sales Value, 2019-2030
5.4.2 North America Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-D Immunoglobulin Sales Value, 2019-2030
5.5.2 Europe Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-D Immunoglobulin Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-D Immunoglobulin Sales Value, 2019-2030
5.7.2 South America Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-D Immunoglobulin Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-D Immunoglobulin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-D Immunoglobulin Sales Value
6.2.1 Key Countries/Regions Anti-D Immunoglobulin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-D Immunoglobulin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-D Immunoglobulin Sales Value, 2019-2030
6.3.2 United States Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-D Immunoglobulin Sales Value, 2019-2030
6.4.2 Europe Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-D Immunoglobulin Sales Value, 2019-2030
6.5.2 China Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-D Immunoglobulin Sales Value, 2019-2030
6.6.2 Japan Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-D Immunoglobulin Sales Value, 2019-2030
6.7.2 South Korea Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-D Immunoglobulin Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-D Immunoglobulin Sales Value, 2019-2030
6.9.2 India Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-D Immunoglobulin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Octapharma
7.1.1 Octapharma Company Information
7.1.2 Octapharma Introduction and Business Overview
7.1.3 Octapharma Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Octapharma Anti-D Immunoglobulin Product Offerings
7.1.5 Octapharma Recent Development
7.2 Kedrion Biopharma
7.2.1 Kedrion Biopharma Company Information
7.2.2 Kedrion Biopharma Introduction and Business Overview
7.2.3 Kedrion Biopharma Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Kedrion Biopharma Anti-D Immunoglobulin Product Offerings
7.2.5 Kedrion Biopharma Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Grifols Anti-D Immunoglobulin Product Offerings
7.3.5 Grifols Recent Development
7.4 Saol Therapeutics
7.4.1 Saol Therapeutics Company Information
7.4.2 Saol Therapeutics Introduction and Business Overview
7.4.3 Saol Therapeutics Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Saol Therapeutics Anti-D Immunoglobulin Product Offerings
7.4.5 Saol Therapeutics Recent Development
7.5 Bayer
7.5.1 Bayer Company Information
7.5.2 Bayer Introduction and Business Overview
7.5.3 Bayer Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bayer Anti-D Immunoglobulin Product Offerings
7.5.5 Bayer Recent Development
7.6 Bio Products Laboratory
7.6.1 Bio Products Laboratory Company Information
7.6.2 Bio Products Laboratory Introduction and Business Overview
7.6.3 Bio Products Laboratory Anti-D Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bio Products Laboratory Anti-D Immunoglobulin Product Offerings
7.6.5 Bio Products Laboratory Recent Development
8 Industry Chain Analysis
8.1 Anti-D Immunoglobulin Industrial Chain
8.2 Anti-D Immunoglobulin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-D Immunoglobulin Sales Model
8.5.2 Sales Channel
8.5.3 Anti-D Immunoglobulin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Anti-D Immunoglobulin Market Trends
Table 2. Anti-D Immunoglobulin Market Drivers & Opportunity
Table 3. Anti-D Immunoglobulin Market Challenges
Table 4. Anti-D Immunoglobulin Market Restraints
Table 5. Global Anti-D Immunoglobulin Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-D Immunoglobulin Revenue Market Share by Company (2019-2024)
Table 7. Global Anti-D Immunoglobulin Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Anti-D Immunoglobulin Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anti-D Immunoglobulin Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Anti-D Immunoglobulin Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anti-D Immunoglobulin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-D Immunoglobulin
Table 13. Global Anti-D Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-D Immunoglobulin as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-D Immunoglobulin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anti-D Immunoglobulin Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anti-D Immunoglobulin Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anti-D Immunoglobulin Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anti-D Immunoglobulin Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anti-D Immunoglobulin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Anti-D Immunoglobulin Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Anti-D Immunoglobulin Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Anti-D Immunoglobulin Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anti-D Immunoglobulin Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anti-D Immunoglobulin Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Anti-D Immunoglobulin Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Anti-D Immunoglobulin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti-D Immunoglobulin Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-D Immunoglobulin Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anti-D Immunoglobulin Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anti-D Immunoglobulin Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anti-D Immunoglobulin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Anti-D Immunoglobulin Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Anti-D Immunoglobulin Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Anti-D Immunoglobulin Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anti-D Immunoglobulin Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anti-D Immunoglobulin Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Anti-D Immunoglobulin Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Anti-D Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anti-D Immunoglobulin Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anti-D Immunoglobulin Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anti-D Immunoglobulin Sales Value by Region (2019-2024) & (%)
Table 44. Global Anti-D Immunoglobulin Sales Value by Region (2025-2030) & (%)
Table 45. Global Anti-D Immunoglobulin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Anti-D Immunoglobulin Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Anti-D Immunoglobulin Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Anti-D Immunoglobulin Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anti-D Immunoglobulin Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anti-D Immunoglobulin Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Anti-D Immunoglobulin Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Anti-D Immunoglobulin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anti-D Immunoglobulin Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anti-D Immunoglobulin Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anti-D Immunoglobulin Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Anti-D Immunoglobulin Sales Volume, (2025-2030) & (K Units)
Table 57. Octapharma Company Information
Table 58. Octapharma Introduction and Business Overview
Table 59. Octapharma Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Octapharma Anti-D Immunoglobulin Product Offerings
Table 61. Octapharma Recent Development
Table 62. Kedrion Biopharma Company Information
Table 63. Kedrion Biopharma Introduction and Business Overview
Table 64. Kedrion Biopharma Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Kedrion Biopharma Anti-D Immunoglobulin Product Offerings
Table 66. Kedrion Biopharma Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Introduction and Business Overview
Table 69. Grifols Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Grifols Anti-D Immunoglobulin Product Offerings
Table 71. Grifols Recent Development
Table 72. Saol Therapeutics Company Information
Table 73. Saol Therapeutics Introduction and Business Overview
Table 74. Saol Therapeutics Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Saol Therapeutics Anti-D Immunoglobulin Product Offerings
Table 76. Saol Therapeutics Recent Development
Table 77. Bayer Company Information
Table 78. Bayer Introduction and Business Overview
Table 79. Bayer Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Bayer Anti-D Immunoglobulin Product Offerings
Table 81. Bayer Recent Development
Table 82. Bio Products Laboratory Company Information
Table 83. Bio Products Laboratory Introduction and Business Overview
Table 84. Bio Products Laboratory Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Bio Products Laboratory Anti-D Immunoglobulin Product Offerings
Table 86. Bio Products Laboratory Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Anti-D Immunoglobulin Downstream Customers
Table 90. Anti-D Immunoglobulin Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-D Immunoglobulin Product Picture
Figure 2. Global Anti-D Immunoglobulin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anti-D Immunoglobulin Sales Volume (2019-2030) & (K Units)
Figure 5. Global Anti-D Immunoglobulin Sales Price (2019-2030) & (US$/Unit)
Figure 6. Anti-D Immunoglobulin Report Years Considered
Figure 7. Global Anti-D Immunoglobulin Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anti-D Immunoglobulin Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-D Immunoglobulin Revenue in 2023
Figure 10. Anti-D Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Vial Picture
Figure 12. Prefilled Syringes Picture
Figure 13. Global Anti-D Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Anti-D Immunoglobulin Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Anti-D Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Anti-D Immunoglobulin Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Anti-D Immunoglobulin Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Anti-D Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Anti-D Immunoglobulin Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Anti-D Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Anti-D Immunoglobulin Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Anti-D Immunoglobulin Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Anti-D Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Anti-D Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Anti-D Immunoglobulin Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Anti-D Immunoglobulin Sales Volume (%), (2019-2030)
Figure 37. United States Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 43. China Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 45. China Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 55. India Anti-D Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Anti-D Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 57. India Anti-D Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 58. Anti-D Immunoglobulin Industrial Chain
Figure 59. Anti-D Immunoglobulin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
